Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APDC + Chemotherapy in Metastatic Colorectal Cancer
NCT02503150Phase 3Unknown
- Sponsor
- Naval Medical University
- Start
- Jul 2015
- Primary completion
- Dec 2019
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
Phase 3, randomised, open-label trial of APDC in metastatic colorectal cancer (mCRC) (2 arms), sponsored by Naval Medical University. Primary endpoint: Progression Free Survival. Status: unknown.
02
Drugs
APDC
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02503150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503150.